PCNSL group N (%) | SCNSL group N (%) | P value | |
---|---|---|---|
Gender | 1.000 | ||
Male | 14 (53.8) | 14 (53.8) | |
Female | 12 (56.2) | 12 (53.8) | |
Age | 0.402 | ||
≤ 60 | 16 (61.5) | 13 (50.0) | |
> 60 | 10 (38.5) | 13 (50.0) | |
Performance Status | 0.026 | ||
0–1 | 10 (38.5) | 18 (69.2) | |
2–4 | 16 (61.5) | 8 (30.8) | |
Multiplicity | 0.011 | ||
Single | 15 (57.7) | 6 (23.1) | |
Multiple | 11 (42.3) | 20 (76.9) | |
Butterfly pattern | 1.000 | ||
Yes | 2 (7.7) | 3 (11.5) | |
No | 24 (92.3) | 23 (88.5) | |
T1Wa | 0.671 | ||
Hypo | 21 (80.8) | 19 (79.2) | |
Iso | 4 (15.4) | 3 (12.5) | |
Hypo-Iso | 0 (0.0) | 1 (4.2) | |
Hyper | 1 (3.8) | 1 (4.2) | |
T2Wb | 0.051 | ||
Hyper | 24 (92.3) | 16 (66.7) | |
Iso | 2 (7.7) | 4 (16.7) | |
Hyper-Iso | 0 (0.0) | 1 (4.2) | |
Hypo | 0 (0.0) | 3 (12.5) | |
T2 Flairc | 0.253 | ||
Hyper | 25 (96.2) | 11 (84.6) | |
Iso or Hypo | 1 (3.8) | 2 (15.4) | |
DWId | 0.049 | ||
Hyper | 26 (100) | 13 (81.3) | |
Non-hyper | 0 (0.0) | 3 (18.8) | |
Enhancement | 0.383 | ||
Homogeneous | 16 (61.5) | 16 (61.5) | |
Patchy | 8 (30.8) | 6 (23.1) | |
Ringlike | 2 (7.7) | 2 (7.7) | |
No enhancement | 0 (0.0) | 2 (7.7) | |
Location of Lesion (s) | |||
Deep grey matter | 12 (46.2) | 18 (69.2) | 0.092 |
White matter | 17 (65.4) | 21 (80.8) | 0.211 |
Cerebellum | 6 (23.1) | 5 (19.2) | 0.734 |
Brainstem | 9 (34.6) | 3 (11.5) | 0.100 |
Supra or Infra | 0.003 | ||
Supratentorial | 17 (65.4) | 17 (65.4) | |
Infratentorial | 6 (23.1) | 0 (0.0) | |
Both | 3 (11.5) | 9 (34.6) | |
Survival statuse | 0.291 | ||
Alive | 23 (88.5) | 19 (73.1) | |
Death | 3 (11.5) | 7 (26.9) |